Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Rotate your site
Louis University Hospital analyzed the electronic health records of 110 men with obesity or Type 2 diabetes to monitor changes in the hormone while taking GLP-1 receptor agonists, such as semgalutide and tirzepatide
A higher-dose version Wegovy HD (7.2 mg) was recently approved in April 2026 with weight loss results closer to 18.7%
Wegovy, which contains semaglutide as its active ingredient, is specifically designed for chronic weight management
Semaglutide tackles appetite suppression and glucose regulation while cyanocobalamin supports healthy metabolism and energy levels
The syringe size does not affect the peptide
US$ 25.59
US$ 20.34
US$ 24.59
US$ 28.77
US$ 20.01
US$ 21.94
US$ 29.70
